The usefulness of measuring creatine kinase MB isoenzyme for diagnosing myocardial infarction when activities of total creatine kinase are very high is unclear. We conducted a retrospective study in an urban hospital that serves a largely indigent population. We concentrated on 146 patients whose creatine kinase activity was >1000 U/L (upper limit of normal: 165 U/L for women and 225 U/L for men), with MB isoenzyme >10 U/L and <5% of total creatine kinase. The positive predictive value of MB isoenzyme (isoimmune method) values >10 U/L was between 11.6% and 56.8% when the value for total creatine kinase exceeded 1000 U/L. Using different values (MB >4% of total creatine kinase) as positive for myocardial infarction would have resulted in far fewer false-positives, but 10 cases of myocardial infarction would have been missed.The mostappropnatecutoffvalue for MB isoenzyme in this population (total creatine kinase >1000 U/L) was found to be >2% of total creatine kinase. . An MB-specific immunochemical procedure described in 1981 (2) has recently been improved by the use of a new substrate (CK-NAC) (3). However, there has been some confusion regarding the upper limit of normal for this assay (3). In the package insert, Roche Diagnostic Systems suggests using a reference range for CK-MB (0-10 UIL) different from that suggested by the Roche "Instrument Application" guide (0-15 U/L if total CK is <500 UIL, and 4% if total CK is >500 U/L). Some studies have suggested that a percentage of total CK be used at higher CK values (3,4), others have argued against using a percentage value (5-7). To examine this issue, we studied patients whose total CK was >1000 UIL, CK-MB was >10 UIL, and CK-MB percentage was <5%. We determined the positive predictive value of the CK-MB in this group of patients and now describe here a large population of patients whose high concentrations of CK-MB are falsely positive for myocardial infarction.
. An MB-specific immunochemical procedure described in 1981 (2) has recently been improved by the use of a new substrate (CK-NAC) (3). However, there has been some confusion regarding the upper limit of normal for this assay (3). In the package insert, Roche Diagnostic Systems suggests using a reference range for CK-MB (0-10 UIL) different from that suggested by the Roche "Instrument Application" guide (0-15 U/L if total CK is <500 UIL, and 4% if total CK is >500 U/L). Some studies have suggested that a percentage of total CK be used at higher CK values (3,4), others have argued against using a percentage value (5) (6) (7) . To examine this issue, we studied patients whose total CK was >1000 UIL, CK-MB was >10 UIL, and CK-MB percentage was <5%. We determined the positive predictive value of the CK-MB in this group of patients and now describe here a large population of patients whose high concentrations of CK-MB are falsely positive for myocardial infarction.
MaterIals and Methods

Methods
Sara were stored at 4#{176}C if not immediately assayed. All samples were analyzed with a CentrifiChem System 500 analyzer (Baker Instruments, Union Carbide Corp., Rye, NY). We used the "Dri-STAT CK-NAC Reagent" (Beckman Instruments, Fullerton, CA) to quantify total CK activity, Departments of' Medicine and2 Pathology, New York University School of Medicine, 550 First Ave., New York, NY 10016.
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and "Isommune-CK" (Roche Diagnostic Systems, Nutley, NJ) with Dri-STAT CK-NAC reagent to quantify CK-MB isoenzyme activity. In all cases we followed the packageinsert directions. When total CK activity exceeded 1200 U/L, we diluted the sample with distilled water and measured it with a Model 3500 analyzer (Gilford Instrument Laboratories, Inc., Oberlin, OH). We used positive control sera at two concentrations. "Lancer CK Isoenzyme" control serum (Sherwood Medical, St. Louis, MO) was used for the CK-MB assay and "Cardiotrol-CK" (Roche Diagnostic Systems) for both the total CK and CK-MB assays.
Dri-STAT CK-NAC Reagent system is based on Oliver's enzymatic sequence as modified by Rosalki (8). Isommune-CK is an immunochemical method based on an immunoprecipitation technique (2).
Patients
We studied all patients admitted to Bellevue Hospital (a 1000-bed municipal hospital) from January through October 1987 whose total CK exceeded 1000 UIL, CK-MB exceeded 10 U/L, and CK-MB percentage of total CK was <5%. Nine of these patients were part of a study on cocaine and myocardial infarction; the remaining 137 were patients for whom the physician requested a CK-MB test to rule out myocardial infarction. The patients were classified into seven diagnostic groups: Group 1 patients (n = 17) were diagnosed as having acute myocardial infarction. Patients in this group had both a history of characteristic chest pain and evolutionary changes indicative of infarction on serial electrocardiograins.
Group 2 (n = 6) consisted of patients with cardiac diagnoses other than myocardial infarction, e.g., congestive heart failure and atrial fibrillation.
Group 3 (n = 45) consisted of patients who had neither a history of chest pain nor evolutionary electrocardiographic changes.
Group 4a patients (n = 12) were patients admitted in shock secondary to trauma or sepsis who had no chest pain or electrocardiographic changes. Group 4b patients (n = 6) were similar, but had undergone cardiopulmonary resuscitation and (or) defibrillation before samples were collected for quantifying CK-MB.
Group 5 (n = 6) consisted of patients who underwent cardiac-bypass surgery.
Group 6 patients (n 25) were classified as equivocal for myocardial infarction, either because they had chest pain (even if atypical) or electrocardiographic changes. Insufficient information was available to make a diagnosis for group 7 patients (n = 29).
Results
Between January and October, tests for CK-MB activities were requested for 2109 patients. Studying the relation of cocaine abuse and myocardial damage was the reason for ordering tests in 188 patients; ruling out myocardial infarction was the reason for ordering tests in the remainder. The highest values for CK and CK-MB were used in this analysis when more than one test was requested for a patient. Nine of the 188(4.8%) cocaine-abusing patients and 137 of the 1921 (7.1%) remaining patients had total CK >1000 U/L, CK-MB >10 UIL, and percentage CK-MB <5%.
The 146 patients ranged in age from three to 94 years (average 54): 73% were male; 38% were white, 29% were black, 25% were Hispanic, and 8% were of Asian origin. Only 17 (11.6%) patients could be definitely classified as myocardial infarction (Group 1). Groups 2, 3, and 4a comprised 63 (43.1%) patients who definitely did not have a myocardial infarction. The remaining 66 patients (Groups  4b, 5,6,7) could not be classified as having or definitely not having had a myocardial infarction. Thus, the positive predictive value of a CK-MB >10 U,L, when total CK is >1000 U/L and the CK-MB percentage of total CK is <5%, is between 11.6% and 56.8%. A positive predictive value of 11.6% (17/146) assumes that all surgical, equivocal, and unclassifiable cases had not had a myocardial infarction, whereas a positive predictive value of 56.8% (83/146) assumes that all surgical, equivocal, and unclassifiable cases had had a myocardial infarction. Table 1 lists probable causes of increased activities of CK-MB in these noninfarct patients (i.e., false-positives).
Trauma was the most common cause, being responsible for or contributing to an increased CK-MB in 29 (46%) cases. Alcohol and drug intoxication contributed to an increase in CK-MB in 16(25%) cases (there was some overlap between the trauma cases and the drug and alcohol cases).
The following case exemplifies a non-infarct-related increase in CK-MB activity: An 85-year-old white woman arrived in the emergency room hypotensive and hypothermic (32 #{176}C). The electrocardiogram showed unifocal premature contractions and nonspecific ST-T wave changes, which were unchanged on the following day. Laboratory data revealed a CK of 2420 UIL and a CK-MB of 118 U/L (4.9% of the total). The day after admission she was taken to surgery, which revealed a transverse colon volvulus and infarction. The patient remained hypotensive and died on the third hospital day. At autopsy, the heart showed no evidence of infarction.
Using the "Instrument Application Guide" recommendation of CK-MB >15 U/L, but a CK-MB percentage >4% if the total CK is >500 UIL, yields a much different picture. Use of these guidelines decreases the number of false positive cases dramatically. Only two patients classified as definitely no myocardial infarction had a CK-MB percentage between 4% and 5%. One of these two patients had septic shock and rhabdomyolysis and the second patient was the women described above. However, these cutoff values lead to some increase in the number of false-negative cases: 10 patients who definitely had a myocardial infarction had a nirnnmum CK-MB percentage <4% and thus would have been incorrectly labeled by these stricter criteria as not having had an infarction. Four of these 10 patients received tissue plasminogen activating factor; two other patients were in shock, which may have contributed to an increase in their total CK activities. Table 2 shows the number of patients allotted to each category as the MB isoenzyme criteria for a positive myocardial infarction change. Use of an absolute value cutoff is unacceptable because of the large number of falsely positive, values. Although using 2% as the cutoff rather than 4% results in an increase in false-positive diagnoses, it substantially decreases the proportion of false-negative diagnoses. Congestive heart failure 3 (1 alcohol-induced cardiomyopathy)
Atnal fibrillation 3 (1 trauma)
Drug-and alcohol-related 10
Cerebral vascular accident 2
Septic shock 3 Unknown mechanism 3
Discussion
The CK-MB isoenzyme is the best laboratory test to evaluate patients with chest pain who present during its first 24 h (9). Therefore, it is important that this test be accurately characterized. It appears that enzyme changes with time are more useful than single determinations (1). Therefore, we used the patient's highest MB activity and the patient's highest percentage MB for the purposes of this study. Previous studies have found that the isoenzyrne is less accurate when the total CK is high but, as mentioned above, there is disagreement about which should be used: absolute MB activity or the percentage of total CK (3) (4) (5) (6) (7) .
To examine this issue, we studied a series of patients in whom the likelthood of false-positive (for myocardial infarction) MB activities was high. Using the criteria described, we identified 63 patients who definitely had not had a myocardial infarction (no chest pain and no changes on electrocardiogram).
Our criteria for diagnosing and ruling out myocardial infarction were conservative, because we classified patients who had atypical chest pain or any nondiagnostic electrocardiographic change as equivocal cases. Numerous causes of an increased MB isoenzyme activity other than myocardial infarction are described in the literature (1, 7, 9). Our study is one of the largest series of increased CK-MB isoenzyme activities not due to myocardial infarction. Trauma was the most common cause, while alcohol and drug abuse also accounted for a substantial proportion of cases. This probably reflects the inner-city, municipal-hospital population studied. The number of falsely positive cases (for myocardial infarction) of MB isoenzyme can be decreased substantially by use of a percentage of total CK when the total CK is high. Our study suggests that the use of 2% rather than 4% as cutoff value will result in fewer cases of missed myocardial infarction. This does result in an increased number of cases not due to myocardial infarction. However, since a falsenegative diagnosis is more harmful than a false-positive diagnosis, we believe the optimal cutoff value for the MB isoenzyme (as measured with the Isomune CK-NAC) should be 15 U/L, but >2% of total CK when the total CK exceeds 1000 UIL. This hypothesis should be tested in other populations, and the utility of the lactate dehydrogenase (EC 1.1.1.27) isoenzyme-1 to differentiate between myocardial infarction cases and non-myocardial infarct cases in populations with high total CK activities should also be tested.
